期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
The Clinical Efficacy of Low-Dose Tacrolimus Combined with Tripterygium to Treat the Steroid-Resistant Nephrotic Syndrome 被引量:3
1
作者 Hongqi Ren Guofang Chen +4 位作者 Xuan Zhou Yan Li Qing Cai shujing han Rui Wang 《Open Journal of Nephrology》 2012年第4期97-104,共8页
Objective: To observe the clinical efficacy and safety of low dose tacrolimus (TAC) combined with tripterygium (TW) in treatment of steroid resistant nephritic syndrome (SRNS). Method: The patients, who were diagnosed... Objective: To observe the clinical efficacy and safety of low dose tacrolimus (TAC) combined with tripterygium (TW) in treatment of steroid resistant nephritic syndrome (SRNS). Method: The patients, who were diagnosed with mesangial proliferative glomerulonephritis (MesPGN) and focal segmental glomerulosclerosis (FSGS) by biopsy and failed to respond to a 3-month treatment with prednisone (1 mg/kg·d), were randomly divided into 2 groups (TAC + TW Group and TW Group). Initially TAC + TW group took TAC 0.05mg/(kg·d) 2 h after meal at 12 h interval. The plasma TAC level was examined after 3 days and was kept at 1.5 - 4 ng·ml;meanwhile, TW was given at 60 mg/d before meal. TW group only took TW (60 mg/d). The efficacy, adverse reactions and plasma TAC levels were observed in each group. Results: 1) Totally 20 SRNS patients completed the trial, 11 of TAC + TW Group and 9 of TW Group. There is no statistical difference between the two groups in terms of age, gender, duration since onset of the disease, blood pressure, 24 h UPQ, serum albumin, creatinine, cholesterol, triglyceride, FBG, kidney pathological categories, time of taking prednisone etc.;2) Urine protein started to decrease after 1 month treatment in both of TAC + TW and TW groups. By the 12th month of treatment, TAC + TW group showed 8 cases of complete remission (72.7%), 2 cases of partial remission (18.2%) and 1 case of no improvement (9.1%), while those of TW groups were 2 (22.2%), 4 (44.5%) and 3 (33.3%), respectively;3) With treatment, the TAC + TW Group patients’ plasma protein was significantly higher than that of pretreatment stage and recovered to normal level after 6 month of treatment. However, there was no significant plasma protein increase in TW Group. No obvious changes were observed on serum creatinine level of patients of both the two groups;4) The incidence of adverse reactions was not significantly different between the two groups. Conclusion: TAC + TW reduced proteinuria of SRNS patients, increased clinical remission rate and was tolerant to SRNS patients. We conclude that TAC + TW treatment is an effective way to treat patients with SRNS. 展开更多
关键词 STEROID-RESISTANT Nephrotic Syndrome TACROLIMUS TRIPTERYGIUM Treatment OUTCOME
暂未订购
Better design leads to better results-Importance of virological outcome design in clinical trials for antiviral treatment of coronavirus disease 2019 被引量:1
2
作者 Getu Zhaori Lu Lu +2 位作者 Chunyan Liu shujing han Yongli Guo 《Pediatric Investigation》 CAS CSCD 2023年第1期1-5,共5页
Since the outbreak of the pandemic coronavirus disease 2019(COVID-19),various articles on different fields of the disease published in medical and related journals increased in a way of explosion.A recent literature s... Since the outbreak of the pandemic coronavirus disease 2019(COVID-19),various articles on different fields of the disease published in medical and related journals increased in a way of explosion.A recent literature search at PubMed using the term“COVID-19”only displayed more than 314000 articles. 展开更多
关键词 clinical treatment explosion
原文传递
Identification of potential pathogenic mutations in Chinese children with first branchial cleft anomalies detected by whole-exome sequencing
3
作者 Yeran Yang Wei Liu +9 位作者 Yaqiong Jin Min Chen Jie Lu Yongbo Yu Huimin Ren shujing han Ping Chu Yongli Guo Jie Zhang Xin Ni 《Pediatric Investigation》 CSCD 2021年第3期211-216,共6页
Importance:First branchial cleft anomalies(FBCAs)are rare congenital malformations,accounting for<8%of all branchial cleft anomalies.However,little is currently known about the cause of FBCAs at the molecular level... Importance:First branchial cleft anomalies(FBCAs)are rare congenital malformations,accounting for<8%of all branchial cleft anomalies.However,little is currently known about the cause of FBCAs at the molecular level.Objective:To identify genomic alterations related to the genetic etiology of FBCAs in Chinese children.Methods:We performed whole-exome sequencing of samples from 10 pediatric patients with FBCAs.Data analysis was carried out using the Burrow-Wheeler Alignment software package,and the dbSNP database for comparisons.Rare variants were further validated by Sanger sequencing.Insertion/deletions(indels)were examined using the Genome Analysis Toolkit.Results:We identified 14 non-synonymous mutations in seven potential FBCA-susceptibility genes(TRAPPC12,NRP2,NPNT,SH3RF2,RHPN1,TENM4,and ARMCX4).We also detected 133 shared small indels in 125 genes.Gene Ontology analysis indicated that most of the identified genes played critical roles in development and differentiation pathways involved in regulating organ development.Interpretation:We characterized the mutational landscape in pathways involved in development and differentiation in Chinese children with FBCA.The results identified potential pathogenic genes and mutations related to FBCA,and provide molecular-level support for the branchial theory of FBCA pathogenesis. 展开更多
关键词 First branchial cleft anomalies(FBCAs) Whole-exome sequencing Development Differentiation
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部